Terms: = Uterine cancer AND MITF, WS2A, ENSG00000187098, 4286 AND Treatment
4 results:
1. uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge.
Natsume T; Yoshida H; Nishikawa T; Kikkawa N; Naka T; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2023 Aug; 31(5):778-784. PubMed ID: 36310451
[TBL] [Abstract] [Full Text] [Related]
2. Familial Kidney cancer: Implications of New Syndromes and Molecular Insights.
Carlo MI; Hakimi AA; Stewart GD; Bratslavsky G; Brugarolas J; Chen YB; Linehan WM; Maher ER; Merino MJ; Offit K; Reuter VE; Shuch B; Coleman JA
Eur Urol; 2019 Dec; 76(6):754-764. PubMed ID: 31326218
[TBL] [Abstract] [Full Text] [Related]
3. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
4. Intravaginal 1-week high-dose-rate brachytherapy alone for Stages I-II endometrial cancer.
Martínez-Monge R; Nagore G; Cambeiro M; Garrán C; Villafranca E; Jurado M
Brachytherapy; 2007; 6(3):195-200. PubMed ID: 17681240
[TBL] [Abstract] [Full Text] [Related]
